Malvern Panalytical to Acquire Micromeritics

Micromeritics Instrument Corp. has agreed to be acquired by Malvern Panalytical, a global leader in the analytics of material and life sciences.

Malvern Panalytical is a leading brand in the laboratory that offers a high-performance range of physical, structural, and elemental analysis products that are highly complementary to Micromeritics‘ technologies.

"Micromeritics is a world leader in particle characterization,” said Terry Kelly, president and CEO at Micromeritics. “Our market-leading technologies are used daily in the labs of the world’s most innovative companies and institutions. Our end markets are strong and growing, and we have a robust new product pipeline. The integration with Malvern Panalytical is powerful. Together our companies will be able to unlock more answers for customers and provide expert applications and technical support that cannot be matched by any other company. The last four and a half years have been an exciting period of growth for Micromeritics, it was a great partnership with SFW Capital. The acquisition by Malvern Panalytical is a perfect fit for our technologies, our customers, and most importantly our people."

“Together, Micromeritics and Malvern Panalytical provide a unique opportunity to create a leading and highly differentiated position and a fully integrated offering in particle characterization,” said Derek Harding, current CFO at Spectris and soon-to-be president of Spectris Scientific. 

“Micromeritics is an excellent business with a strong track record of growth and innovation and excellent future growth prospects. It will be a great addition to Malvern Panalytical and will strengthen our position in a number of key end markets benefiting from long-term, secular and sustainability growth trends, as well as accelerating sales of each other’s offerings. We look forward to welcoming the Micromeritics team and providing our customers with a wider portfolio of market leading solutions, helping to enhance their processes and productivity.”

The acquisition agreement is subject to approval from US authorities. Until approval is received, and the transaction complete, Spectris, Malvern Panalytical, and Micromeritics will continue to operate as usual and as independent businesses.